Impaired processing speed and attention in first-episode drug naive schizophrenia with deficit syndrome

Schizophrenia Research

Volumn 159, Issue 2-3, 2014, Pages 478-484

  Chen, Ce ^a   Jiang, Wenhui ^a   Zhong, Na ^b   Wu, Jin ^a   Jiang, Haifeng ^b   Du, Jiang ^b   Li, Ye ^a   Ma, Xiancang ^a   Zhao, Min ^b   Hashimoto, Kenji ^c   Gao, Chengge ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Attention; Cognition; Deficit syndrome; Processing speed; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION DISTURBANCE; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; COGSTATE COMPUTERIZED COGNITIVE BATTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MENTAL PERFORMANCE; MENTAL TASK; NEGATIVE SYNDROME; SCHEDULE FOR DEFICIT SYNDROME; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 84922432145     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.005     Document Type: Article

References (54)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, D.C. 4th ed.
2. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157:549-559.
3. Bosc M., Dubini A., Polin V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur. Neuropsychopharmacol. 1997, 7(Suppl. 1):S57-S70. (discussion S71-53).
4. Bryson G., Whelahan H.A., Bell M. Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res. 2001, 102:29-37.
5. Buchanan R.W., Strauss M.E., Kirkpatrick B., Holstein C., Breier A., Carpenter W.T. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch. Gen. Psychiatry 1994, 51:804-811.
6. Busner J., Targum S.D. The Clinical Global Impression Scale. Applying a research tool in clinical practice. Psychiatry (Edgmont) 2007, 4:28-37.
7. Carpenter W.T. Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry 2007, 6:92-93.
8. Carpenter W.T., Heinrichs D.W., Wagman A.M.I. Deficit and non-deficit forms of schizophrenia: the concept. Am. J. Psychiatry 1988, 145:578-583.
9. Carrión R.E., Goldberg T.E., McLaughlin D., Auther A.M., Correll C.U., Cornblatt B.A. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am. J. Psychiatry 2011, 168:806-813.
10. Chapman L.J., Chapman J.P. Problems in the measurement of cognitive deficit. Psychol. Bull. 1973, 79:380-385.
11. Cohen A.S., Saperstein A.M., Gold J.M., Kirkpatrick B., Carpenter W.T., Buchanan R.W. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr. Bull. 2007, 33:1201-1212.
12. Cohen A.S., Brown L.A., Minor K.S. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis. Schizophr. Res. 2010, 118:122-127.
13. Csukly G., Polgár P., Tombor L., Benkovits J., Réthelyi J. Theory of mind impairments in patients with deficit schizophrenia. Compr. Psychiatry 2014, 55:349-356.
14. Elvevag B., Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 2000, 14:1-21.
15. Frommann I., Pukrop R., Brinkmeyer J., Bechdolf A., Ruhrmann S., Berning J., Decker P., Riedel M., Möller H.J., Wölwer W., Gaebel W., Klosterkötter J., Maier W., Wagner M. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early- and additional memory dysfunction in the late-prodromal state. Schizophr. Bull. 2011, 37:861-873.
16. Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., Stieglitz R.D., Vita A., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry 2012, 69:562-571.
17. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 1996, 153:321-330.
18. Harvey P.D., Keefe R.S.E. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am. J. Psychiatry 2001, 158:176-184.
19. Horan W.P., Blanchard J.J. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr. Res. 2003, 65:125-137.
20. Jones S.H., Thornicroft G., Coffey M., Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br. J. Psychiatry 1995, 166:654-659.
21. Kanahara N., Sekine Y., Haraguchi T., Uchida Y., Hashimoto K., Shimizu E., Iyo M. Orbitofrontal cortex abnormality and deficit schizophrenia. Schizophr. Res. 2013, 143:246-252.
22. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
23. Keefe R.S., Harvey P.D. Cognitive impairment in schizophrenia. Handb. Exp. Pharmacol. 2012, 213:11-37.
24. Keefe R.S., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004, 68:283-297.
25. Kirkpatrick B. Progress in the study of negative symptoms. Schizophr. Bull. 2014, 40(Suppl. 2):S101-S106.
26. Kirkpatrick B., Galderisi S. Deficit schizophrenia: an update. World Psychiatry 2008, 7:143-147.
27. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., Carpenter W.T. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989, 30:119-123.
28. Kirkpatrick B., Conley R.C., Kakoyannis A., Reep R.L., Roberts R.C. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 1999, 34:95-102.
29. Kirkpatrick B., Buchanan R.W., Ross D.E., Carpenter W.T. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 2001, 58:165-171.
30. Kirkpatrick B., Messias N.C., Conley R.R., Roberts R.C. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J. Nerv. Ment. Dis. 2003, 191:563-567.
31. Kopelowicz A., Liberman R.P., Mintz J., Zarate R. Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. Am. J. Psychiatry 1997, 154:424-425.
32. Kopelowicz A., Zarate R., Tripodis K., Gonzalez V., Mintz J. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am. J. Psychiatry 2000, 157:987-993.
33. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol. Psychiatry 2006, 59:863-871.
34. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 1999, 46:729-739.
35. Malaspina D., Coleman E. Olfaction and social drive in schizophrenia. Arch. Gen. Psychiatry 2003, 60:578-584.
36. Maruff P., Thomas E., Cysique L., Brew B., Collie A., Snyder P., Pietrzak R.H. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch. Clin. Neuropsychol. 2009, 24:165-178.
37. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23:315-336.
38. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 2005, 162:495-506.
39. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry 1999, 56:749-754.
40. Murthy N.V., Mahncke H., Wexler B.E., Maruff P., Inamdar A., Zucchetto M., Lund J., Shabbir S., Shergill S., Keshavan M., Kapur S., Laruelle M., Alexander R. Computerized cognitive remediation training for schizophrenia: an open label, multi-site, multinational methodology study. Schizophr. Res. 2012, 139:87-91.
41. Niarchou N., Zammit S., Walters J., Lewis G., Own M.J., va den Bree M.B. Defective proceeding speed and nonclinical psychotic experiences in children longitudinal analyses in a large birth cohort. Am. J. Psychiatry 2013, 170:550-557.
42. Pegoraro L.F., Dantas C.R., Banzato C.E., Fuentes D. Correlation between insight dimensions and cognitive functions in patients with deficit and non-deficit schizophrenia. Schizophr. Res. 2013, 147:91-94.
43. Pietrzak R.H., Olver J., Norman T., Piskulic D., Maruff P., Snyder P.J. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J. Clin. Exp. Neuropsychol. 2009, 31:848-859.
44. Pietrzak R.H., Snyder P.J., Jackson C.E., Olver J., Norman T., Piskulic D., Maruff P. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals. Hum. Psychopharmacol. 2009, 24:113-121.
45. Putnam K.M., Harvey P.D. Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophr. Bull. 2000, 26:867-878.
46. Réthelyi J.M., Czobor P., Polgár P., Mersich B., Bálint S., Jekkel E., Magyar K., Mészáros A., Fábián A., Bitter I. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262:107-115.
47. Rund B.R. Is schizophrenia a neurodegenerative disorder?. Nord. J. Psychiatry 2009, 63:196-201.
48. Saxena S., Carlson D., Billington R. The WHO quality of life assessment instrument (WHOQOL-Bref): the importance of its items for cross-cultural research. Qual Life Res. 2001, 10:711-721.
49. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 1994, 51:124-131.
50. Simon A.E., Cattapan-Ludewig K., Zmilacher S., Arbach D., Gruber K., Dvorsky D.N., Roth B., Isler E., Zimmer A., Umbricht D. Cognitive functioning in the schizophrenia prodrome. Schizophr. Bull. 2007, 33:761-771.
51. Tse W.S., Bond A.J. Psychometric analysis of the Chinese version of Social Adaptation Self-evaluation Scale (C-SASS). Psychiatry Res. 2007, 153:277-281.
52. Xia P., Li N., Hau K.T., Liu C., Lu Y. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med. Res. Methodol 2012, 12:37.
53. Yoshida T., Suga M., Arima K., Muranaka Y., Tanaka T., Eguchi S., Lin C., Yoshida S., Ishikawa M., Higuchi Y., Seo T., Ueoka Y., Tomotake M., Keneda Y., Darby D., Maruff P., Iyo M., Kasai K., Higuchi T., Sumiyoshi T., Ohmori T., Takahashi K., Hashimoto K. Criterion and constract validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. PLoS ONE 2011, 6:e20469.
54. Zhong N., Jiang H., Wu J., Chen H., Lin S., Zhao Y., Du J., Ma X.C., Chen C., Gao C., Hashimoto K., Zhao M. Reliability and validity of the CogState battery Chinese language version in schizophrenia. PLoS ONE 2013, 8:e74258.